IL47084A - Substituted 3-carbonly(or thiocarbonyl)amino sulfonyl pyridines - Google Patents

Substituted 3-carbonly(or thiocarbonyl)amino sulfonyl pyridines

Info

Publication number
IL47084A
IL47084A IL47084A IL4708475A IL47084A IL 47084 A IL47084 A IL 47084A IL 47084 A IL47084 A IL 47084A IL 4708475 A IL4708475 A IL 4708475A IL 47084 A IL47084 A IL 47084A
Authority
IL
Israel
Prior art keywords
carbonly
thiocarbonyl
substituted
amino sulfonyl
sulfonyl pyridines
Prior art date
Application number
IL47084A
Other languages
English (en)
Other versions
IL47084A0 (en
Original Assignee
Christiaens Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christiaens Sa A filed Critical Christiaens Sa A
Publication of IL47084A0 publication Critical patent/IL47084A0/xx
Publication of IL47084A publication Critical patent/IL47084A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL47084A 1974-04-17 1975-04-14 Substituted 3-carbonly(or thiocarbonyl)amino sulfonyl pyridines IL47084A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1683674A GB1477664A (en) 1974-04-17 1974-04-17 Pyridine derivatives
YU1507/81A YU42409B (en) 1974-04-17 1981-06-15 Process for obtaining new pyridine derivatives

Publications (2)

Publication Number Publication Date
IL47084A0 IL47084A0 (en) 1975-06-25
IL47084A true IL47084A (en) 1979-01-31

Family

ID=26252269

Family Applications (1)

Application Number Title Priority Date Filing Date
IL47084A IL47084A (en) 1974-04-17 1975-04-14 Substituted 3-carbonly(or thiocarbonyl)amino sulfonyl pyridines

Country Status (19)

Country Link
US (2) US4018929A (en, 2012)
JP (1) JPS5951536B2 (en, 2012)
AR (4) AR211097A1 (en, 2012)
AT (1) AT344170B (en, 2012)
BE (1) BE827844A (en, 2012)
CA (1) CA1070313A (en, 2012)
CH (3) CH609045A5 (en, 2012)
DD (2) DD121936A5 (en, 2012)
DE (1) DE2516025A1 (en, 2012)
ES (4) ES436581A1 (en, 2012)
FR (1) FR2267775B1 (en, 2012)
GB (1) GB1477664A (en, 2012)
HU (1) HU171420B (en, 2012)
IL (1) IL47084A (en, 2012)
LU (2) LU72284A1 (en, 2012)
NL (2) NL183580C (en, 2012)
SE (2) SE424320B (en, 2012)
YU (1) YU42409B (en, 2012)
ZA (1) ZA752243B (en, 2012)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
US4776878A (en) * 1978-12-04 1988-10-11 E. I. Du Pont De Nemours And Company Agricultural pyridinesulfonamides
LU85193A1 (fr) * 1984-01-31 1985-09-12 Christiaens Sa A Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
US4853389A (en) * 1987-07-24 1989-08-01 American Home Products Corporation Diuretic and antihypertensive substituted-5-pyrimidinesulfonylureas
US4914203A (en) * 1987-07-24 1990-04-03 American Home Products Corporation 5 step process for preparing certain 2,4-diamino-5-pyrimidine-sulfonyl ureas
FR2659080B1 (fr) * 1990-03-02 1994-07-08 Adir Nouveaux derives de la pyridylsulfonyluree et de la pyridylsulfonylthiouree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5166162A (en) * 1990-03-02 1992-11-24 Adir Et Compagnie Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
US5486530A (en) * 1991-04-27 1996-01-23 Boehringer Mannheim Gmbh Use of torasemide for the treatment of brain oedemas
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
HRP980532B1 (en) 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US6166045A (en) * 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
HRP20020120A2 (en) * 1999-08-11 2003-10-31 Teva Pharma Torsemide polymorphs
EP1292303B1 (en) * 2000-02-17 2004-05-12 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation comprising torsemide modification ii
NZ521852A (en) 2000-03-20 2004-10-29 Teva Pharma Novel processes for preparing torsemide intermediate
HRP20000162B1 (en) 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
EP1741429A3 (en) * 2000-03-20 2007-01-17 Teva Pharmaceutical Industries Ltd. Processes for preparing torsemide
HRP20000328A2 (en) * 2000-05-19 2002-02-28 Pliva Farmaceutska Ind Dionik Novel polymorph v of torasemide
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
IN192178B (en, 2012) 2001-08-03 2004-03-06 Ranbaxy Lab
IL149771A0 (en) * 2002-05-21 2002-11-10 Fintech Lab Ltd Process for preparation of torsemide
HRP20020603B1 (en) * 2002-07-19 2008-11-30 Pliva D.D. New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
DE60336485D1 (de) 2002-08-19 2011-05-05 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
CA2401546C (en) * 2002-09-06 2006-09-19 Brantford Chemicals Inc. Preparation of derivatives of 3-sulfonamido-4-phenylaminopyridine
ITMI20022749A1 (it) * 2002-12-23 2004-06-24 Cosma S P A Nuovo procedimento per la sintesi della tosemide, in particolare della forma ii pura e stabile.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20050215600A1 (en) * 2003-10-27 2005-09-29 Arie Gutman Polymorphs of torsemide hydrochloride and process for production thereof
US7378527B2 (en) * 2004-03-16 2008-05-27 Daqing Che Process for the preparation of torsemide and related intermediates
EP1951702A2 (en) * 2005-10-17 2008-08-06 NeuroTherapeutics Pharma, Inc. Diuretic-like compound analogs useful for regulation of central nervous system disorders
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7625896B2 (en) * 2005-11-25 2009-12-01 Hoffman-La Roche Inc. Pyridylsulfonamide derivatives
US7939532B2 (en) * 2006-10-26 2011-05-10 Hoffmann-La Roche Inc. Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US7879884B2 (en) * 2007-05-16 2011-02-01 Hoffmann-La Roche Inc. Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
NL2006622C2 (en) 2011-04-18 2012-10-22 Eurovet Animal Health B V Use of a composition comprising torasemide.
WO2014014519A1 (en) 2012-07-20 2014-01-23 University Of Rochester Method of treating and preventing brain impairment using na+-k+ -2ci- cotransporter isoform 1 inhibitors
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
IL273065B2 (en) 2015-02-16 2024-01-01 Univ Queensland Sulfonylureas and related compounds and their uses
EP3661925B1 (en) 2017-07-07 2021-11-24 Inflazome Limited Novel sulfonamide carboxamide compounds
CN113574055B (zh) 2019-01-18 2024-07-23 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法
WO2021171230A1 (en) * 2020-02-28 2021-09-02 Cadila Healthcare Limited Novel substituted sulfonylurea and sulfoximineurea derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674794A (en) * 1970-03-18 1972-07-04 Ciba Geigy Corp Certain-3-pyridine-sulfonamide derivatives
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
US3904636A (en) * 1971-11-09 1975-09-09 Christiaens Sa A 3-sulfonamido-4-phenyl aminopyridines and derivatives
GB1414793A (en) * 1972-07-28 1975-11-19 Manuf Prod Pharma Derivatives of phenylaminopyridine

Also Published As

Publication number Publication date
CH610890A5 (en, 2012) 1979-05-15
USRE30633E (en) 1981-06-02
NL940014I2 (nl) 1997-04-01
DD126887A5 (en, 2012) 1977-08-17
FR2267775A1 (en, 2012) 1975-11-14
NL7504521A (nl) 1975-10-21
ES453328A1 (es) 1977-11-01
NL940014I1 (nl) 1994-09-16
JPS50142571A (en, 2012) 1975-11-17
AR208768A1 (es) 1977-02-28
ES436581A1 (es) 1977-04-01
ATA288275A (de) 1977-11-15
JPS5951536B2 (ja) 1984-12-14
AR208770A1 (es) 1977-02-28
SE424320B (sv) 1982-07-12
NL183580B (nl) 1988-07-01
CH609045A5 (en, 2012) 1979-02-15
DE2516025C2 (en, 2012) 1988-11-03
DE2516025A1 (de) 1975-11-06
AT344170B (de) 1978-07-10
CH612424A5 (en, 2012) 1979-07-31
HU171420B (hu) 1978-01-28
BE827844A (fr) 1975-10-13
ES453329A1 (es) 1977-11-16
SE7504409L (sv) 1975-10-20
ZA752243B (en) 1976-03-31
ES453327A1 (es) 1977-11-16
IL47084A0 (en) 1975-06-25
GB1477664A (en) 1977-06-22
LU72284A1 (en, 2012) 1975-08-20
YU42409B (en) 1988-08-31
CA1070313A (en) 1980-01-22
AR211097A1 (es) 1977-10-31
FR2267775B1 (en, 2012) 1978-11-10
NL183580C (nl) 1988-12-01
AR208769A1 (es) 1977-02-28
AU8001675A (en) 1976-10-14
US4018929A (en) 1977-04-19
LU88346I2 (fr) 1994-05-04
SE7907618L (sv) 1979-09-13
DD121936A5 (en, 2012) 1976-09-05
YU150781A (en) 1984-02-29

Similar Documents

Publication Publication Date Title
IL47084A (en) Substituted 3-carbonly(or thiocarbonyl)amino sulfonyl pyridines
JPS5183277A (en) Ea fuirutano ryuryoseigyosochi
IL46960A0 (en) Fastener
PH14207A (en) N-(1-benzylpyrrolidinyl 2-alkyl)substituted benzamides
AU7748475A (en) Benzylamine derivatives
ZA755897B (en) Fastener
IL48375A (en) 2-trifluoromethyl-4-methylthio (sulfinyl or sulfonyl) methanesulfonanilides and process for their preparation
JPS511482A (en) Shinki 22 amino 1 33 chiajinruino seizohoho
ZA753347B (en) Improved roofing member
ZA753095B (en) Detonating fusecord
AU7927375A (en) Benzenesulfonyl ureas
IL47113A (en) Substituted 3-carbonyl (or thiocarbonyl) amino sulfonyl pyridines
AU8222075A (en) Pyrimidine sulfonamides
JPS5117191A (en) Haikigasuchuno so3 nojokyohoho
HK80079A (en) Amino acid derivatives
CS186291B2 (en) Locating member
ZA75300B (en) Novel sulfonyl ureas
JPS5136477A (en) Arufua amino ipushiron kapurorakutamu no tanriho
AU8003675A (en) Diamino pyridines
JPS5158078A (en) Ic memori
JPS5158576A (en) Amino mutankahoho
JPS5139634A (en) Ganma amino beeta hidorokishibutansananirido no seizoho
GB1520777A (en) Herbicidal n-substituted alph-haloacetanilides
JPS5134831A (en) Kinzoku no yokaiho
JPS5137045A (en) Denkainyoru kinzoku no yokaiho